These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 304500)

  • 1. Reactivity of HLA typing sera against cultured lymphoblastoid cell lines and purified peripheral B and T cells from the same original donors.
    Nakayama E; Itakura K
    Jpn J Exp Med; 1977 Oct; 47(5):425-7. PubMed ID: 304500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA typing of leukemic cells and lymphoblastoid cell lines: effects of non-HLA antibodies in common typing sera.
    DuBois D; Specian TL; Pollack MS
    Prog Clin Biol Res; 1977; 16():115-28. PubMed ID: 269454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplification of B-cell antisera of the Merrit system with platelets and lymphoblastoid cell lines.
    Naeim F; Gregg B; Gatti RA; Leibold W; Walford RL
    Transplant Proc; 1977 Mar; 9(1):439-44. PubMed ID: 68582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
    Feighery CF; Stastny P
    Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRw alloantigens can be detected on peripheral blood T lymphocytes.
    Mann DL; Sharrow SO
    J Immunol; 1980 Nov; 125(5):1889-96. PubMed ID: 7000892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of reactivity of HLA-Cw antisera by extending the incubation time.
    Wong DM; Kumar R; Mittal KK
    Acta Anthropogenet; 1983; 7(3):197-203. PubMed ID: 6335043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in the capacity of HLA sera to react with T- and B-lymphocyte populations].
    Zotikov EA; Tananov AT
    Biull Eksp Biol Med; 1976 Jun; 81(6):698-9. PubMed ID: 60152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
    Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen heterogeneity of human B and T lymphocytes.
    Rabellino EM; Grey HM; LaForge S; Pirofsky B; Kashiwagi N; Malley A
    J Clin Invest; 1976 Feb; 57(2):390-7. PubMed ID: 815274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.
    Winchester RJ; Wernet P; Kunkel HG; Dupont B; Jersild C; Fu SM
    J Exp Med; 1975 Apr; 141(4):924-9. PubMed ID: 47890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and functional characterization of primary alloreactive human T lymphocytes.
    Kornbluth J; Dupont B
    J Exp Med; 1980 Aug; 152(2 Pt 2):164s-181s. PubMed ID: 6967934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
    LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
    Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterophile antibodies in the sera from renal transplant recipients.
    Akiyama N; Mori T; Kusaba R; Inou T; Kawamura A
    Jpn J Exp Med; 1978 Dec; 48(6):519-24. PubMed ID: 374802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of circulating maternal T and B lymphocytes in uncomplicated severe combined immunodeficiency by HLA typing of subpopulations of T cells separated by the fluorescence-activated cell sorter and of Epstein Barr virus-derived B cell lines.
    Geha RS; Reinherz E
    J Immunol; 1983 Jun; 130(6):2493-5. PubMed ID: 6304187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificities in natural cell-mediated cytotoxicity against lymphoblastoid cell lines. I. Selective inhibition by cross-competition.
    Koide Y; Takasugi M
    Eur J Immunol; 1978 Nov; 8(11):818-22. PubMed ID: 82513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.